Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

HMGA2 Gene Expression in Fine-needle Aspiration Samples of Thyroid Nodules as a Marker for Preoperative Diagnosis of Thyroid Cancer

HMGA2 Gene Expression in Fine-needle Aspiration Samples of Thyroid Nodules as a Marker for... There is a great interest in molecular markers that would help in the preoperative diagnosis of malignant thyroid nodules in cases of indeterminate fine-needle aspiration cytology. The aim of this study was to determine the diagnostic accuracy of HMGA2 gene expression in discriminating benign from malignant thyroid nodules. In this study, 237 preoperative thyroid fine-needle aspiration samples were analyzed prospectively for the expression of the HMGA2 gene by real-time reverse transcription polymerase chain reaction. The results were evaluated against the postoperative histopathologic diagnosis or definitive cytologic diagnosis in cases of nodular goiter and Hashimoto thyroiditis. Among 237 samples from patients with thyroid nodules that were analyzed, 231 were adequate for real-time reverse transcription polymerase chain reaction analysis. With a cutoff value of 8.71 for relative gene expression, HMGA2 was positive in 19 (16.4%) of 116 nodular goiter, 1 (2.6%) of 39 Hashimoto thyroiditis, 9 (28.1%) of 32 follicular adenoma, 0 (0%) of 5 Hurthle cell adenoma, 32 (88.9%) of 36 papillary carcinoma, and 3 (100%) of 3 follicular carcinoma samples. In discriminating between malignant and benign thyroid nodules, HMGA2 has shown specificity of 84.5%, sensitivity of 91.9%, positive predictive value of 53.1%, and negative predictive value of 98.2%. High sensitivity and negative predictive value of HMGA2 for preoperative detection of malignant thyroid nodules shown in this study indicate that it may have a role as an ancillary marker in cytology in the management of patients with thyroid nodules. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

HMGA2 Gene Expression in Fine-needle Aspiration Samples of Thyroid Nodules as a Marker for Preoperative Diagnosis of Thyroid Cancer

Download PDF
6 pages

Loading next page...
 
/lp/wolters-kluwer-health/hmga2-gene-expression-in-fine-needle-aspiration-samples-of-thyroid-7Qk0h5CTNZ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1541-2016
eISSN
1533-4058
DOI
10.1097/PAI.0000000000000637
Publisher site
See Article on Publisher Site

Abstract

There is a great interest in molecular markers that would help in the preoperative diagnosis of malignant thyroid nodules in cases of indeterminate fine-needle aspiration cytology. The aim of this study was to determine the diagnostic accuracy of HMGA2 gene expression in discriminating benign from malignant thyroid nodules. In this study, 237 preoperative thyroid fine-needle aspiration samples were analyzed prospectively for the expression of the HMGA2 gene by real-time reverse transcription polymerase chain reaction. The results were evaluated against the postoperative histopathologic diagnosis or definitive cytologic diagnosis in cases of nodular goiter and Hashimoto thyroiditis. Among 237 samples from patients with thyroid nodules that were analyzed, 231 were adequate for real-time reverse transcription polymerase chain reaction analysis. With a cutoff value of 8.71 for relative gene expression, HMGA2 was positive in 19 (16.4%) of 116 nodular goiter, 1 (2.6%) of 39 Hashimoto thyroiditis, 9 (28.1%) of 32 follicular adenoma, 0 (0%) of 5 Hurthle cell adenoma, 32 (88.9%) of 36 papillary carcinoma, and 3 (100%) of 3 follicular carcinoma samples. In discriminating between malignant and benign thyroid nodules, HMGA2 has shown specificity of 84.5%, sensitivity of 91.9%, positive predictive value of 53.1%, and negative predictive value of 98.2%. High sensitivity and negative predictive value of HMGA2 for preoperative detection of malignant thyroid nodules shown in this study indicate that it may have a role as an ancillary marker in cytology in the management of patients with thyroid nodules.

Journal

Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health

Published: Jul 1, 2019

References

  • Thyroid cancer mortality and incidence: a global overview
  • Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology
  • Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity
  • Fine-needle aspiration of thyroid nodules: past, present, and future
  • A large multicenter correlation study of thyroid nodule cytopathology and histopathology
  • Molecular signature of indeterminate thyroid lesions: current methods to improve fine needle aspiration cytology (FNAC) diagnosis
  • Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay
  • High mobility group a proteins as tumor markers
  • HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias
  • Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias
  • HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules
  • HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR
  • The diagnostic utility of combination of HMGA2 and IMP3 qRT-PCR testing in thyroid neoplasms
  • Three-gene molecular diagnostic model for thyroid cancer
  • Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms
  • A panel of four genes accurately differentiates benign from malignant thyroid nodules
  • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
  • The Bethesda system for reporting thyroid cytopathology
  • 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer
  • Preoperative diagnosis of benign thyroid nodules with indeterminate cytology
  • European Thyroid Association Guidelines regarding thyroid nodule molecular fine-needle aspiration cytology diagnostics
  • Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology
  • Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytology
  • Thyroid fine-needle aspiration samples inadequate for reverse transcriptase-polymerase chain reaction analysis
  • Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR
  • The Bethesda system for reporting thyroid cytopathology: a meta-analysis
  • Croatia has reached iodine sufficiency